Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial |
---|---|
Contact name | Howard Trachtman/Peter Yuen |
Contact phone | 301-402-6702 |
Contact email | petery@intra.niddk.nih.gov |
PI name | Howard Trachtman |
Site approved dt | March 10, 2008, midnight |